Login
Toggle navigation
Videos
Categories
Trending
Teleborsa S.p.A. interviews Alessio Aceti, CEO of Sababa Security.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Alessio Aceti is the CEO of Sababa Security.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
John Taylor, Chairman and CEO of FX Concepts, Discusses the Future of Forex, Political and Economic Risks, and Evolution of FX Strategies
00:00:00
Jan Adriaan (Arjan) Haverhals Chief Executive Officer and President, Milestone Scientific Inc
00:10:00
Summer Associate Training at Wilson Sonsini | Miranda Biven - PARTNER of Wilson Sonsini
00:10:00
Their goal is to accelerate the emergence of the open metaverse by investing in the founders, companies|Andrew Steinwold,Managing Partner,Sfermion
00:10:00
Thunderful Group Expands Portfolio with Acquisition of Robot Teddy | Brjann Sigurgeirsson, CEO, Thunderful Group AB.
00:10:00
invests in the brands and technology that power the future|Brian Sugar,Founder and Partner,Sugar Capital
00:10:00
Hot Chili's Low-Cost, High-Impact Copper Project: Key Insights and Future Plans
00:10:00
Société Générale’s Positive Impact Week | Slawomir Krupa, CEO, Société Générale.
00:10:00
Henry Owsley, CEO of Gordian Group, discusses distressed M&A and restructuring strategies in his MandA.TV interview.
00:10:00
Galena Mining: Advancing the Abra Base Metals Project in Western Australia
00:10:00
All Canadian investment dealers with trading operations have access to the CSE|Michael Dake,CEO,American Salars Lithium Inc
00:10:00
Iain Conn discusses CEO succession at Centrica in the interim financial report.